For laboratory and Research Use Only
One of its benefits is that it works well on all skin tones and types, unlike lasers
The most 3 TSS gives rise to the shorter, major message (GSTF8-S) that is much more stress-responsive than the longer transcript (GSTF8-L) originating from an upstream TSS, which encodes the larger form of the protein

When dose reduction makes sense (and when it doesn't) Dose reduction is a reasonable strategy in specific situations: When dose reduction makes sense: You've reached your weight loss goal and want to transition to maintenance dosing You're experiencing persistent side effects (nausea, constipation, reflux) that don't resolve after 4+ weeks at current dose Cost is prohibitive and stepping down one dose level is financially sustainable You're on 14 mg and have achieved satisfactory weight loss at 7 mg in the past When dose reduction doesn't make sense: You're still actively losing weight and tolerating current dose well You've plateaued and your provider is considering dose escalation You're reducing dose to "take a break" from side effects without addressing underlying causes (diet, hydration, meal timing) You're reducing dose because you're worried about long-term medication use (GLP-1 agonists have excellent long-term safety data

doi: 10.1111/aji.13593 163 FadinMNicolettiMCPellizzatoMAccardiMBaiettiMGFratterA
That said, clinicians have explored PT-141 in men for years, particularly in cases involving: Erectile dysfunction (ED) Low libido Psychogenic ED Poor response to PDE5 inhibitors What the Research Suggests Early studies involving men with erectile dysfunction showed improvements in erectile function scores and sexual response, including in men with diabetes-related ED